The kinetics of β-methyl-substituted labelled fatty acids in ischaemic myocardium: An analysis in man and with a blood-perfused isolated heart model

European Journal of Nuclear Medicine

Volumn 26, Issue 5, 1999, Pages 474-482

  Marie, Pierre Y ^a,e   Menu, Patrick ^b   Angioï, Michaël ^a   Mertes, Paul M ^a   Ayalew, Adey ^a   Hassan, Nathalie ^a   Olivier, Pierre ^a   Fagret, Daniel ^c   Karcher, Gilles ^a   Danchin, Nicolas ^a   Pasqualini, Roberto ^d   Bertrand, Alain ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d CIS Bio International   (France)

^e INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Free fatty acids; Ischaemia; Methyl branched fatty acids; Single photon emission tomography; Thallium 201

Indexed keywords

FATTY ACID; HEPTADECANOIC ACID; IODINE 123; THALLIUM 201;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLEARANCE; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; FEMALE; HEART MUSCLE ISCHEMIA; HEART SCINTISCANNING; HUMAN; ISOLATED HEART; ISOTOPE LABELING; MALE; NONHUMAN; RABBIT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; FEMALE; HEART; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PALMITIC ACIDS; RABBITS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0032948255     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050413     Document Type: Article

References (44)

1. 1. Van der Wall EE. Myocardial imaging with radiolabeled free fatty acids: applications and limitations. Eur J Nucl Med 1986; 12: S11-S15.
2. 123I-labeled-16-hexadecanoic acid. Eur J Nucl Med 1983; 8: 211-217.
3. 3. Schön HR, Senekowitsch R, Berg D, Schneidereit M, Reidel G, Kriegel H, Pabst HW, Blömer H. Measurement of myocardial fatty acid metabolism: kinetics of iodine-123 heptadecanoic acid in normal dog hearts. J Nucl Med 1986; 27: 1449-1455.
4. 4. Fagret D, Wolf JE, Pilichowski P, Mathieu JP, Pernin C, Apparu M, Arvieux C, Cuchet P, Vidal M, Comet M. Iodomethylated fatty acid metabolism in mice and dogs. Eur J Nucl Med 1988; 14:624-627.
5. 5. Demaison L, Dubois F, Apparu M, Mathieu JP, Vidal M, Comet M, Cuchet P. Myocardial metabolism of radioiodinated methyl-branched fatty acids. J Nucl Med 1988; 29: 1230-1236.
6. 6. Fink GD, Montgomery JA, David F, Garneau M, Livini E, Elmaleh D, Strauss W, Brunengraber H. Metabolism of β-methyl-heptadecanoic acid in the reperfused rat heart and liver. J Nucl Med 1990; 31: 1823-1830.
7. 7. Knapp FF. Myocardial metabolism of radioiodinated BMIPP. J Nucl Med 1995; 36: 1051-1054.
8. 123I-pPPA) scintigraphy. Nucl Med Commun 1992; 13: 168-185.
9. 123/131I-phenyl)-pentadecanoic acid (pPPA) in animals and man. J Nucl Med 1990; 31: 1608-1616.
10. 10. Knapp FF, Kropp J. Iodine-123-labelled fatty acids for myocardial single-photon emission tomography: current status and future perspectives. Eur J Nucl Med 1995; 25: 361-381.
11. 11. Knapp FF, Kropp J, Franken PR, Visser FC, Sloof GW, Eisenhut M, Yamamichi, Schirakami Y, Kusuoka H, Nishimura T. Pharmacokinetics of radiodinated fatty acid myocardial irnaging agents in animal models and human studies. J Nucl Med 1996; 40: 252-269.
12. 12. Sloof GW, Visser FC, Bax JJ, Eersels J, Knapp FF, Teule GJJ. Increased uptake of iodine-123-BMIPP in chronic ischaemic heart disease: comparison with fluorine-18-FDG SPET. J Nucl Med 1998; 39: 255-260.
13. 123I]-16-iodo3-R,S-methyl hexadecanoic acid in patients with myocardial infarction. Comparison with thallium 201 uptake and wall motion. Am J Card Imaging 1994; 8: 1-7.
14. 123I]-16-iodo3-methyl-hexadecanoic acid imaging in patients with myocardial infarction: analysis of defect reversibility. J Nucl Med 1995; 36: 1561-1568.
15. 201Tl technique. J Am Coll Cardiol 1997; 30: 1241-1248.
16. 16. Kuikka JT, Mussalo H, Hietakorpi S, Vanninen E, Läsimies E. Evaluation of myocardial viability with technetium-99 m hexakis-2-methoxyisobutyl isonitrile and iodine-123 phenylpentadecanoic acid and single photon emission tomography. Eur J Nucl Med 1992; 19: 882-889.
17. 17. Iskandrian AS, Powers J, Cave V, Wasserleben V, Cassel D, Jaekyeong H. Assessment of myocardial viability by dynamic tomographic iodine 123 iodophenylpentadecanoic acid imaging: comparison with rest-redistribution thallium imaging. J Nucl Cardiol 1995; 2: 101-109.
18. 18. Murray G, Schad N, Ladd W, Allie D, Vander Zwang R, Avet P, Rockett J. Metabolic cardiac imaging in severe coronary disease: assessment of viability with iodine-123-iodophenylpentadecanoic acid and multicrystal gamma camera, and correlation with biopsy. J Nucl Med 1992; 33: 1269-1277.
19. 201Tl tomography in myocardial infarction. J Nucl Med 1991; 32: 1353-1357.
20. 20. Tamaki N, Kawamoto M, Yonekura Y, Fujibayashi Y, Takahashi N, Konishi J, Nohara R, Kambara H, Kawai C, Ikekubo K, Kato H. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med 1992; 33: 659-667.
21. 21. Franken PR, De Geeter F, Dendale P, Demoor D, Block P, Bossuyt A. Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve. J Nucl Med 1994; 35: 1758-1765.
22. 22. Sloof GW, Visser FC, Bax JJ, van Lingen A, Eersel J, Knapp FF, Geritt JJ. Increased uptake of iodine-123-BMIPP in chronic ischaemic heart disease: comparison with fluorine-18-FDG SPET. J Nucl Med 1998; 39: 255-260.
23. 23. Lerch RA, Bergmann SR. Non invasive assessment of myocardial fatty acid metabolism with positron emission tomography and gamma imaging. In: Pohost GM, Higgins CB, Morganroth J, Ritchie JL, Schelbert HR (eds.) New concepts in cardiac imaging, 4th edn. Chicago; Year Book Medical Publishers; 1988; 4: 91-116.
24. 123I-labelled fatty acids. Eur J Nucl Med 1986; 13: S36-S38.
25. 2 tension in local control of coronary blood flow. Am J Physiol 1990; 258: H1388-H1394.
26. 26. Mouren S, Souktani R, Beaussier M. Mechanisms of coronary vasoconstriction induced by high arterial oxygen tension. Am J Physiol 1997; 272: H67-H75.
27. 27. Danchin N, Juillière Y, Foley D, Serruys PW. Visual versus quantitative assessment of the severity of coronary artery stenoses: can the angiographer's eye be reeducated ? Am Heart J 1993; 126: 571-577.
28. 28. Bergmann SR, Clarck RE, Burton ES. An improved isolated heart preparation for external assessment of myocardial metabolism. Am J Physiol 1979; 236: H644-H651.
29. 29. Gewirtz H, Fischman AJ, Abraham S, Gilson M, Strauss HW, Alpert NM. Positron emission tomographic measurements of absolute regional myocardial flow permits identification of nonviable myocardium in patients with chronic myocardial infarction. J Am Coll Cardiol 1994; 23: 851-859.
30. 201Tl extraction, washout and retention at varying coronary flow rates in rabbit heart. Circulation 1990; 82: 998-1007.
31. 201Tl kinetics in normal and ischaemic myocardium. Circulation 1981; 64: 610-618.
32. 201Tl after stress in normal and perfusion-reduced canine myocardium. Am J Cardiol 1985; 56: 969-973.
33. 11C-palmitate. Circulation 1982; 65: 731-738.
34. 34. Visser FC, Westera G, Eenige van MJ, Van der Wall EE, Den Hollander W, Roos JP. The myocardial elimination rate of radioiodinated heptadecanoic acid. Eur J Nucl Med 1985; 10: 118-122.
35. 35. Van der Wall EE, Westera G, Den Hollander W, Visser FC. External detection of regional myocardial metabolism with radioiodinated hexadecenoic acid in the dog heart. Eur J Nucl Med 1981; 6: 147-151.
36. 36. Opie LH. Substrate and energy metabolism of the heart. In: Sperelakis N (ed.) Physiology and pathophysiology of the heart. Dordrecht: Nijhoff; 1984: 301-336.
37. 37. Miller DD, Gill JB, Livni E, Elmaleh DR, Aretz T, Boucher CA, Strauss W. Fatty acid accumulation: a marker of myocyte viability in ischaemic-reperfused myocardium. Circ Res 1988; 63: 681-692.
38. 38. Opie LH. Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction. Am J Cardiol 1975; 36: 938-953.
39. 39. Severson DL, Hurley B. Regulation of rat heart triacylglycerol ester hydrolases by free fatty acids, fatty acyl CoA and fatty acyl carnitine. J Mol Cell Cardiol 1982; 14: 467-474.
40. 40. Fox KAA, Namura H, Sobel BE. Consistent substrate utilization despite reduced flow in hearts with maintained work. Am J Physiol 1983; 244: H799-H806.
41. 41. Abendschein DR, Fox KAA, Knab RM, Ambos HD, Elmaleh DR, Bergmann SR. The metabolic fate of 11C-beta methyl heptadecanoic acid (BMHA) in myocardium subjected to ischaemia [abstract]. Circulation 1984; 70 (Suppl II): 148.
42. 201Tl uptake in reperfused and nonreperfused myocardial infarction. Circ Res 1983; 53: 414-419.
43. 43. Forman R, Kirk ES. Thallium-201 accumulation during reperfusion of ischaemic myocardium: dependence on regional blood flow rather than viability. Am J Cardiol 1984; 54: 659-663.
44. 44. Lopaschuk GD, Stanley WC. Glucose metabolism in the ischaemic heart. Circulation 1997; 95: 313-315.